Jeffrey P. Crandall

Davis Polk is advising Novo Nordisk A/S on its acquisition of Corvidia Therapeutics Inc. for an upfront payment of $725 million in cash. Total payments to Corvidia Therapeutics shareholders…

Davis Polk advised Dean Foods Company on the sale of substantially all of Dean Foods’s assets and business operations pursuant to Section 363 of the Bankruptcy Code to six third party…

Davis Polk is advising Varagon Capital Partners, L.P. on its agreement to form a new strategic partnership with Aflac Global Investments and the extension of its existing strategic…

Davis Polk is advising The Charles Schwab Corporation on its $26 billion all-stock acquisition of TD Ameritrade Holding Corporation. Under the agreement, TD Ameritrade stockholders will…

Davis Polk is advising Whitney Wolfe Herd, the founder and CEO of Bumble, in connection with the acquisition by Blackstone of a majority stake in MagicLab, which builds and operates leading…

Davis Polk is advising Hudson Group in connection with its acquisition of a controlling stake in the assets of OHM Concession Group LLC. The addition of OHM adds notable food and beverage…

Davis Polk is advising an ad hoc group (the “Ad Hoc Group”) of prepetition superpriority secured lenders and post-petition DIP lenders holding in excess of $1 billion of secured debt issued…

Davis Polk is advising Hudson Group in connection with its acquisition of assets related to the operation of Brookstone stores in U.S. airports from Apex Digital, Inc. Hudson has also…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its acquisition of assets of IBM’s Algorithmics business. The transaction is expected to close in the fourth quarter of 2019,…

Davis Polk advised TPG Capital, the private equity platform of global alternative asset firm TPG, on its acquisition of Convey Health Solutions from New Mountain Capital and related…